ACTIVE

APOTHEEK DAEM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

44,5 k €

+77.1% YoY

Gross margin

70,6 k €

+59.6% YoY

Equity

341,5 k €

+15.0% YoY

What does APOTHEEK DAEM do?

APOTHEEK DAEM is a Private limited company incorporated in 2001. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Liedekerke.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0475.968.112

Incorporation

31/10/2001

Legal form

Private limited company

Registered office

Gravenbosstraat 81
1770 Liedekerke · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	70,6 k €	+59.6%	44,2 k €	-51.0%	90,2 k €	-40.2%	150,8 k €	-2.6%	154,8 k €	-1.8%	157,7 k €	+27.3%	123,8 k €	-1.8%	126,1 k €	+3.0%	122,3 k €	-9.5%	135,2 k €	-4.5%	141,5 k €	+6.3%	133,1 k €	-26.7%	181,7 k €	+3.7%	175,2 k €	+11.0%	157,8 k €	+33.9%	117,8 k €	+28.5%	91,7 k €	+19.9%	76,5 k €	-12.2%	87,1 k €	+15.0%	75,8 k €
EBITDA	68,7 k €	+61.9%	42,4 k €	-22.9%	55 k €	-12.9%	63,2 k €	-16.6%	75,8 k €	+2.8%	73,7 k €	+45.5%	50,7 k €	-31.7%	74,2 k €	+16.0%	64 k €	-11.0%	71,9 k €	+3.6%	69,4 k €	+13.9%	60,9 k €	-44.2%	109,1 k €	+1.0%	108,1 k €	-23.3%	140,9 k €	+36.7%	103,1 k €	+34.7%	76,5 k €	+36.2%	56,1 k €	-32.6%	83,3 k €	+12.8%	73,9 k €
Operating result	60,3 k €	+76.6%	34,2 k €	-21.6%	43,6 k €	-17.1%	52,6 k €	-9.2%	58 k €	+75.0%	33,1 k €	+4725%	-716,4 €	-103%	26,4 k €	+63.4%	16,2 k €	-27.5%	22,3 k €	-5.8%	23,7 k €	+60.8%	14,7 k €	-77.7%	66 k €	+13.7%	58,1 k €	-4.4%	60,7 k €	+16.9%	51,9 k €	+21.9%	42,6 k €	+80.2%	23,7 k €	-41.8%	40,6 k €	+31.9%	30,8 k €
Net result	44,5 k €	+77.1%	25,1 k €	-23.8%	33 k €	-15.7%	39,1 k €	-9.2%	43,1 k €	+75.2%	24,6 k €	+570%	-5,2 k €	-135%	15,1 k €	+162%	5,8 k €	-51.5%	11,9 k €	-3.0%	12,3 k €	+110%	5,8 k €	-84.7%	38,2 k €	+8.9%	35,1 k €	+0.8%	34,8 k €	+4.5%	33,3 k €	+29.3%	25,8 k €	+100%	12,9 k €	-42.6%	22,4 k €	+22.8%	18,3 k €
Balance sheet
Equity	341,5 k €	+15.0%	297 k €	+9.2%	271,8 k €	-17.3%	328,9 k €	+13.5%	289,7 k €	+17.5%	246,7 k €	+11.1%	222,1 k €	-2.3%	227,3 k €	+7.1%	212,2 k €	+2.8%	206,4 k €	+6.1%	194,5 k €	+6.7%	182,2 k €	+111%	86,4 k €	-46.7%	162,1 k €	+27.6%	127,1 k €	+37.7%	92,3 k €	+56.5%	58,9 k €	-29.1%	83,2 k €	+18.3%	70,3 k €	+46.8%	47,9 k €
Total assets	525,8 k €	+27.6%	412,2 k €	+6.7%	386,4 k €	-13.6%	447,2 k €	+11.7%	400,5 k €	+14.6%	349,6 k €	-10.4%	390,3 k €	-11.7%	442,2 k €	-2.3%	452,8 k €	-4.6%	474,8 k €	-11.3%	535,1 k €	+3.6%	516,3 k €	-9.4%	570 k €	-1.8%	580,6 k €	-5.8%	616,3 k €	-1.2%	623,8 k €	+81.2%	344,2 k €	+5.1%	327,4 k €	-6.7%	351 k €	-5.1%	370 k €
Cash	149,4 k €	+60.7%	92,9 k €	+24.0%	74,9 k €	-53.5%	161,1 k €	+28.4%	125,4 k €	+90.7%	65,8 k €	+18.6%	55,5 k €	-40.2%	92,7 k €	+7.6%	86,2 k €	+24.5%	69,3 k €	+0.9%	68,7 k €	+3.8%	66,1 k €	-29.8%	94,2 k €	+27.6%	73,9 k €	+7.7%	68,6 k €	-74.8%	272,5 k €	+242%	79,6 k €	+53.1%	52 k €	-1.9%	53 k €	+8.7%	48,8 k €
Debts	184,3 k €	+60.0%	115,2 k €	+0.6%	114,5 k €	-3.1%	118,2 k €	+6.7%	110,8 k €	+7.7%	102,8 k €	-38.8%	167,9 k €	-21.7%	214,5 k €	-10.7%	240,1 k €	-10.3%	267,7 k €	-21.2%	339,9 k €	+2.7%	330,8 k €	-31.5%	482,8 k €	+15.5%	418 k €	-14.4%	488 k €	-8.0%	530,3 k €	+86.3%	284,7 k €	+17.4%	242,6 k €	-10.0%	269,5 k €	-14.2%	314,1 k €
Other
Workforce	–		–		0,4 ETP	-66.7%	1,2 ETP	+9.1%	1,1 ETP	-21.4%	1,4 ETP	+27.3%	1,1 ETP	+10.0%	1,0 ETP	-50.0%	2,0 ETP	+53.8%	1,3 ETP	-43.5%	2,3 ETP	-23.3%	3,0 ETP	+50.0%	2,0 ETP	+66.7%	1,2 ETP	+100%	0,6 ETP	0.0%	0,6 ETP	-33.3%	0,9 ETP	0.0%	0,9 ETP	+800%	0,1 ETP	-66.7%	0,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Gravenbos Farma

Director · 0769.920.078

Active

Ended mandates

Geertrui DAEM

Director · until 31 mai 2023

Ended

Geertrui DAEM

Director

Ended

Geertrui DAEM

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	14/11/2025	30/08/2024	09/10/2023	30/09/2022	09/09/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	12/09/2023	25/05/2022	26/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	31/08/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	14/11/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	12/09/2023	09/10/2023	Dutch	PDF
Abridged model	31/12/2021	25/05/2022	30/09/2022	Dutch	PDF
Abridged model	31/12/2020	26/05/2021	09/09/2021	Dutch	PDF
Abridged model	31/12/2019	09/10/2020	06/11/2020	Dutch	PDF
Abridged model	31/12/2018	29/05/2019	14/08/2019	Dutch	PDF
Abridged model	31/12/2017	30/05/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	31/05/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	25/05/2016	29/08/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	24/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	29/07/2014	Dutch	PDF
Abridged model	31/12/2012	26/06/2013	16/07/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	24/08/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	26/08/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	28/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	17/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	25/07/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	31/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Gravenbos Farma

Director · 0769.920.078

Active

Ended mandates

Geertrui DAEM

Director · until 31 mai 2023

Ended

Geertrui DAEM

Director

Ended

Geertrui DAEM

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/06/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares07/02/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202544,5 k €↑
2024
Annual accounts 202425,1 k €↓
2023
Annual accounts 202333 k €↓
2022
Annual accounts 202239,1 k €↓
2021
Annual accounts 202143,1 k €↑
2020
Annual accounts 202024,6 k €↑
2019
Annual accounts 2019-5,2 k €↓
2018
Annual accounts 201815,1 k €↑
2017
Annual accounts 20175,8 k €↓
2016
Annual accounts 201611,9 k €↓
2015
Annual accounts 201512,3 k €↑
2014
Annual accounts 20145,8 k €↓
2013
Annual accounts 201338,2 k €↑
2012
Annual accounts 201235,1 k €↑
2011
Annual accounts 201134,8 k €↑
2010
Annual accounts 201033,3 k €↑
2009
Annual accounts 200925,8 k €↑
2008
Annual accounts 200812,9 k €↓
2007
Annual accounts 200722,4 k €↑
2006
Annual accounts 200618,3 k €
31/10/2001
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK DAEM

Overview

What does APOTHEEK DAEM do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline